NCT00915122View on ClinicalTrials.gov

Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2010

Study Completion Date

October 24, 2023

Conditions
Adenocarcinoma of the Prostate
Interventions
RADIATION

Dose Escalated IMRT

Patients will receive external beam RT 55.1Gy in 29 once daily fractions to pelvic lymph nodes/prostate/seminal vesicles followed by 24.7Gy in 13 once daily fractions to the prostate/seminal vesicles using intensity modulated radiation therapy.

Trial Locations (1)

M5G 2M9

University Health Network, Princess Margaret Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT00915122 - Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate | Biotech Hunter | Biotech Hunter